33.46
+0.44(+1.33%)
Currency In USD
| Previous Close | 33.02 |
| Open | 32.99 |
| Day High | 33.6 |
| Day Low | 32.72 |
| 52-Week High | 49.83 |
| 52-Week Low | 28.83 |
| Volume | 796,105 |
| Average Volume | 1.3M |
| Market Cap | 1.91B |
| PE | -2.29 |
| EPS | -14.64 |
| Moving Average 50 Days | 33.12 |
| Moving Average 200 Days | 39.97 |
| Change | 0.44 |
If you invested $1000 in Enovis Corporation (ENOV) 10 years ago, it would be worth $431.33 as of July 03, 2025 at a share price of $33.46. Whereas If you bought $1000 worth of Enovis Corporation (ENOV) shares 5 years ago, it would be worth $677.36 as of July 03, 2025 at a share price of $33.46.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Enovis Announces Appointment of Damien McDonald as Chief Executive Officer
GlobeNewswire Inc.
Apr 02, 2025 10:30 AM GMT
Damien McDonald appointed CEO, effective as of May 12, 2025Company reiterates guidance for first quarter revenues and aEBITDA WIlmington. DE, April 02, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “The Company”) (NYSE: ENOV), a leader
Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025
GlobeNewswire Inc.
Mar 25, 2025 12:00 PM GMT
Alongside an evidence-based portfolio, Enovis will showcase how it’s “Redefining Every Step” with confidence-building education and a partnership that goes beyond the product; attendees invited to exclusive events. Enovis Featured Products at ACFAS 2
Enovis Announces Planned CEO Succession Process
GlobeNewswire Inc.
Feb 26, 2025 11:00 AM GMT
Wilmington, DE, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), a leader in medical technology innovation, announced today that Matt Trerotola has informed the Board of Directors (the “Board”) of his